- Home
- WYY vs AEON Comparison
WYY vs AEON Comparison
Compare WYY & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- AEON
- Stock Information
- Founded
- WYY 1991
- AEON N/A
- Country
- WYY United States
- AEON United States
- Employees
- WYY N/A
- AEON N/A
- Industry
- WYY EDP Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- AEON Health Care
- Exchange
- WYY Nasdaq
- AEON Nasdaq
- Market Cap
- WYY 32.7M
- AEON 36.4M
- IPO Year
- WYY 1998
- AEON N/A
- Fundamental
- Price
- WYY $3.89
- AEON $0.70
- Analyst Decision
- WYY Strong Buy
- AEON Strong Buy
- Analyst Count
- WYY 1
- AEON 1
- Target Price
- WYY $7.00
- AEON $5.00
- AVG Volume (30 Days)
- WYY 84.1K
- AEON 92.5K
- Earning Date
- WYY 11-13-2024
- AEON 11-19-2024
- Dividend Yield
- WYY N/A
- AEON N/A
- EPS Growth
- WYY N/A
- AEON N/A
- EPS
- WYY N/A
- AEON N/A
- Revenue
- WYY $124,237,872.00
- AEON N/A
- Revenue This Year
- WYY $25.94
- AEON N/A
- Revenue Next Year
- WYY $13.22
- AEON N/A
- P/E Ratio
- WYY N/A
- AEON N/A
- Revenue Growth
- WYY 23.44
- AEON N/A
- 52 Week Low
- WYY $1.65
- AEON $0.64
- 52 Week High
- WYY $4.55
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- WYY 56.14
- AEON 33.27
- Support Level
- WYY $3.57
- AEON $0.69
- Resistance Level
- WYY $4.19
- AEON $0.88
- Average True Range (ATR)
- WYY 0.17
- AEON 0.06
- MACD
- WYY 0.03
- AEON -0.02
- Stochastic Oscillator
- WYY 58.35
- AEON 13.64
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.